POLICY NAME | ||
---|---|---|
Agency |
...
e.g., ONC, FDA, HHS | Docket# | Type: NPRM |
Date: Comments must be received before |
...
: [enter deadline] | Method: Comments should be submitted through the federal register |
...
Type of publication: Policy notification (called?), RFI, NPRM, Final policy language (others/notice of info collection?)
Summary:
Paragraph or
Two
(or more? - brooke, how long?)
Potential main points +/- questions under each if relevant
...
Will require PH to be certified by ONC without additional funding
Do PHAs have funding for this? Do you anticipate meeting these requirements today/soon?
...
Will set up a new department for disease reporting from locals
What are your concerns about changes to disease reporting? What would help you? Could you talk about problems you face today with dz reporting?
...
/other: [add link] | ||
Summary: | ||
Brief summary of the rule. More detailed impacts and/or specific questions can be provided for each priority area of interest. | ||
Identified Impacts for Public Health Laboratories | ||
Priority Areas for Requested Feedback: | ||
Topic Area 1: Questions for Feedback & Discussion | ||
High-Level Topic Summary: Feedback Needed:
| ||
Topic Area 2: Questions for Feedback & Discussion | ||
High-Level Topic Summary: Feedback Needed:
| ||
Topic Area 3: Questions for Feedback & Discussion | ||
High-Level Topic Summary: Feedback Needed:
|